The intricate world of chemical synthesis is fundamental to advancements in medicine. Within this domain, specific intermediates serve as the bedrock for creating complex pharmaceutical agents. One such compound, (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide (CAS: 521284-19-5), stands out for its role in developing treatments for significant health conditions, including diabetes.

As a prominent supplier and manufacturer in China, we are dedicated to providing high-purity intermediates like (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide. This compound, appearing as an Off-White to Pale Yellow Solid, possesses a molecular formula of C16H16N2O4 and a molecular weight of 300.31. Its utility is primarily found in its application as a pharmaceutical intermediate, particularly in the creation of (aminothiazolyl)acetanilide derivatives, which are critical in diabetes therapy research.

The synthesis of this vital intermediate often involves complex multi-step processes designed to ensure maximum purity and yield. Understanding these chemical synthesis pathways is crucial for optimizing production and ensuring the quality of the final pharmaceutical product. When researchers or companies look to buy this compound, they seek reliability and consistency, attributes we strive to deliver as a China-based manufacturer.

The properties of (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide, such as its melting point (116-119°C) and solubility (Slightly in DMSO, Methanol), are key considerations for its practical application. These physical characteristics inform how it is handled and incorporated into larger synthetic schemes. This precision is what makes it a sought-after component in advanced organic synthesis.

Moreover, the compound is recognized as a Mirabegron intermediate, linking it to established pharmaceutical products. This connection highlights its importance in the broader pharmaceutical landscape. The ongoing research into its applications means that the demand for reliable sourcing, often from experienced manufacturers in China, remains high. Price considerations for bulk purchases are also a significant factor for global research initiatives.

In summary, (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide is a cornerstone intermediate for pharmaceutical development. Its contribution to diabetes treatment research and its role as a versatile building block in organic synthesis underscore its value. For those seeking to advance medical science, particularly in the area of metabolic disorders, this compound is an essential resource, readily available from dedicated manufacturers.